We are live on
!
Find out more
NCM
Northside Capital Management Portfolio holdings
AUM
$1.22B
1-Year Est. Return
20.77%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+20.77%
3 Year Est. Return
+94.84%
5 Year Est. Return
+115.45%
10 Year Est. Return
+286.92%
AUM
$378M
AUM Growth
+$13.7M
(+3.7%)
Cap. Flow
-$2.22M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
77.45%
Holding
100
New
6
Increased
6
Reduced
19
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.69M |
| 2 |
Snowflake
SNOW
|
+$1.85M |
| 3 |
Datadog
DDOG
|
+$770K |
| 4 |
Procore
PCOR
|
+$711K |
| 5 |
Planet Labs
PL
|
+$662K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vir Biotechnology
VIR
|
+$1.62M |
| 2 |
Microsoft
MSFT
|
+$1.55M |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
+$1.42M |
| 4 |
Roblox
RBLX
|
+$1.36M |
| 5 |
Oracle
ORCL
|
+$924K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 29.12% |
| 2 | Technology | 21.5% |
| 3 | Financials | 5.57% |
| 4 | Healthcare | 3.68% |
| 5 | Industrials | 1.98% |
Similar funds
DGM
GC
SC
CCM
AG
DPI
IB
IA
Northside Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Northside Capital Management held 100 positions worth $378M, up 3.7% from $365M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Northside Capital Management's Q4 2021 filing shows 6 new, 6 increased, 19 reduced and 7 closed positions. Its largest new stake was Procore: 8,119 shares worth $649K. The largest sale was Vir Biotechnology, an estimated $1.62M.
By sector, the portfolio is most concentrated in Communication Services at 29% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
- Northside Capital Management's largest Q4 2021 buy was Procore: 8,119 shares worth $649K.
- Northside Capital Management added most to Meta Platforms (Facebook) in Q4 2021, an estimated $3.69M increase.
- Northside Capital Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $1.55M.
- Northside Capital Management fully exited Vir Biotechnology in Q4 2021, selling an estimated $1.62M.
- Northside Capital Management's ten largest holdings make up 77% of its $378M portfolio in Q4 2021.
- Northside Capital Management opened 6 new positions and closed 7 in Q4 2021.
- Northside Capital Management's portfolio value rose 3.7% quarter-over-quarter to $378M.
Based on Northside Capital Management's 13F filing for Q4 2021, filed 24 Jan 2022.